Young Men's Myocarditis Risk 5 Times Higher With Moderna vs Pfizer Vax

(MedPage Today) -- Risk of heart inflammation following the second dose of an mRNA COVID-19 vaccine was substantially higher in younger men with Moderna's product (Spikevax) versus Pfizer/BioNTech's (Comirnaty), though some of this risk was reduced...